Pharmacological Development of Target-Specific Delocalized Lipophilic Cation-Functionalized Carboranes for Cancer Therapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Development of Target-Specific Delocalized Lipophilic Cation-Functionalized Carboranes for Cancer Therapy
Authors
Keywords
anticancer therapeutics, cancer cells, DLC-carboranes, normal cells, p53/p21 axis
Journal
PHARMACEUTICAL RESEARCH
Volume 33, Issue 8, Pages 1945-1958
Publisher
Springer Nature
Online
2016-04-26
DOI
10.1007/s11095-016-1930-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Strategies in Cancer Nanomedicine
- (2016) Rong Tong et al. Annual Review of Pharmacology and Toxicology
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review)
- (2016) IOANNIS S. VIZIRIANAKIS et al. ONCOLOGY REPORTS
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
- (2015) Joseph Madak et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy
- (2015) Maja Sochalska et al. FEBS Journal
- Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents
- (2015) Josephine Modica-Napolitano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- p53, a translational regulator: contribution to its tumour-suppressor activity
- (2015) V Marcel et al. ONCOGENE
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Getting to the Source: Selective Drug Targeting of Cancer Stem Cells
- (2014) Fatima Ismail et al. ChemMedChem
- Dequalinium induces cytotoxicity in human leukemia NB4 cells by downregulation of Raf/MEK/ERK and PI3K/Akt signaling pathways and potentiation of specific inhibitors of these pathways
- (2014) Ana I. García-Pérez et al. LEUKEMIA RESEARCH
- New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells
- (2014) Roberto Würth et al. Biomed Research International
- Towards boron neutron capture therapy: The formulation and preliminary in vitro evaluation of liposomal vehicles for the therapeutic delivery of the dequalinium salt of bis-nido-carborane
- (2013) Dimitrios Theodoropoulos et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The prognostic value of apoptotic and proliferative markers in breast cancer
- (2013) Charla C. Engels et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects ofTP53mutational status on gene expression patterns across 10 human cancer types
- (2013) Neha Parikh et al. JOURNAL OF PATHOLOGY
- Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements
- (2012) Ioannis S. Vizirianakis et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting cancer cell mitochondria as a therapeutic approach
- (2012) Shijun Wen et al. Future Medicinal Chemistry
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Baicalin increases VEGF expression and angiogenesis by activating the ERR /PGC-1 pathway
- (2010) K. Zhang et al. CARDIOVASCULAR RESEARCH
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
- (2009) Divya Pathania et al. ADVANCED DRUG DELIVERY REVIEWS
- WNT16B Is a New Marker of Cellular Senescence That Regulates p53 Activity and the Phosphoinositide 3-Kinase/AKT Pathway
- (2009) R. Binet et al. CANCER RESEARCH
- Carborane-based derivatives of delocalised lipophilic cations for boron neutron capture therapy: synthesis and preliminary in vitro evaluation
- (2008) Gianpiero Calabrese et al. JOURNAL OF MATERIALS CHEMISTRY
- From delocalized lipophilic cations to hypoxia: Blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors
- (2008) Metin Kurtoglu et al. MOLECULAR NUTRITION & FOOD RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now